Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies

Por Hegde, Upendra P., Mukherji, Bijay
Publicado no Cancer Immunol Immunother (2017)

Radiofrequency ablation of lymphoma

Por Sudheendra, Deepak, Barth, Mara M., Hegde, Upendra, Wilson, Wyndham H., Wood, Bradford J.
Publicado em 2006

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Untreated Diffuse Large B-cell Lymphoma with Analysis of Germinal Center and Post-Germinal Center Biomarkers

Por Wilson, Wyndham H., Dunleavy, Kieron, Pittaluga, Stefania, Hegde, Upendra, Grant, Nicole, Steinberg, Seth M., Raffeld, Mark, Gutierrez, Martin, Chabner, Bruce A., Staudt, Louis, Jaffe, Elaine S., Janik, John E.
Publicado em 2008

Randomized Double-blind Placebo-controlled Trial of Celecoxib for Oral Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

Por Lalla, Rajesh V., Choquette, Linda E., Curley, Kathleen F., Dowsett, Robert J., Feinn, Richard S., Hegde, Upendra P., Pilbeam, Carol C., Salner, Andrew L., Sonis, Stephen T., Peterson, Douglas E.
Publicado no Oral Oncol (2014)

MHC-I restricted Melanoma Antigen Specific TCR Engineered Human CD4(+) T Cells Exhibit Multifunctional Effector and Helper Responses, In Vitro

Por Ray, Swagatam, Chhabra, Arvind, Chakraborty, Nitya G., Hegde, Upendra, Dorsky, David I., Chodon, Thinle, von Euw, Erika, Comin-Anduix, Begonya, Koya, Richard C., Ribas, Antoni, Economou, James S., Rosenberg, Steven A., Mukherji, Bijay
Publicado em 2010

RBTT-07. A PHASE 2 TRIAL OF PEMBROLIZUMAB AND BEVACIZUMAB IN MELANOMA BRAIN MET PATIENTS

Por Kluger, Harriet M, Forsyth, Peter, Khushalani, Nikhil, Eroglu, Zeynep, Sznol, Mario, Tran, Thuy, Jilaveanu, Lucia, Cohen, Justine V, Hegde, Upendra, Wei, Wei, Mahajan, Amit, Goldberg, Sarah B, Chiang, Veronica, Weiss, Sarah A
Publicado no Neuro Oncol (2019)

Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy

Por Diaz, Patricia I., Hong, Bo-Young, Dupuy, Amanda K., Choquette, Linda, Thompson, Angela, Salner, Andrew L., Schauer, Peter K., Hegde, Upendra, Burleson, Joseph A., Strausbaugh, Linda D., Peterson, Douglas E., Dongari-Bagtzoglou, Anna
Publicado no J Fungi (Basel) (2019)

Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

Por Kluger, Harriet M., Chiang, Veronica, Mahajan, Amit, Zito, Christopher R., Sznol, Mario, Tran, Thuy, Weiss, Sarah A., Cohen, Justine V., Yu, James, Hegde, Upendra, Perrotti, Elizabeth, Anderson, Gail, Ralabate, Amanda, Kluger, Yuval, Wei, Wei, Goldberg, Sarah B., Jilaveanu, Lucia B.
Publicado no J Clin Oncol (2019)

A Phase II trial of pembrolizumab for patients with melanoma or non-small cell lung cancer and untreated brain metastases

Por Goldberg, Sarah B., Gettinger, Scott N., Mahajan, Amit, Chiang, Anne C., Herbst, Roy S., Sznol, Mario, Tsiouris, Apostolos John, Cohen, Justine, Vortmeyer, Alexander, Jilaveanu, Lucia, Yu, James, Hegde, Upendra, Speaker, Stephanie, Madura, Matthew, Ralabate, Amanda, Rivera, Angel, Rowen, Elin, Gerrish, Heather, Yao, Xiaopan, Chiang, Veronica, Kluger, Harriet M.
Publicado no Lancet Oncol (2016)